DCIS recurrence: what it means and what happens next

A new imaging abnormality or breast change is not automatically a recurrence. Scarring, fat necrosis and other benign changes may resemble disease, which is why clinicians compare current and earlier imaging and use biopsy when needed.

A local recurrence appears in the same breast after breast-conserving treatment. Pathology establishes whether the new cells are confined to ducts or have become invasive. A new cancer can also arise elsewhere in either breast and may not be biologically identical to the original DCIS. The location, receptor findings, previous margins and treatments already received all affect how the new diagnosis is interpreted.

The usual assessment begins with a clinical examination and targeted breast imaging. If the finding remains concerning, a breast biopsy identifies the tissue change. Bring prior mammograms, operation notes, pathology reports and radiotherapy details because comparison can prevent gaps in planning. Treatment depends on whether the recurrence is DCIS or invasive, its extent and what local treatment the breast received before.

After an earlier lumpectomy, another local operation or mastectomy may be discussed according to the new site and previous care. Hormone therapy may be considered when receptor findings make it relevant. A confirmed invasive recurrence requires its own staging and treatment discussion.

Contact the breast clinic for a new or enlarging lump, bloody nipple discharge, nipple inversion, skin dimpling, persistent focal pain or a change along the surgical scar. Also respond to a recall after mammography even if you feel well, because DCIS recurrence may appear on imaging without causing symptoms. Seek urgent medical attention for severe illness or rapidly spreading redness with fever, which may indicate an infection that needs prompt care.

Ask the specialist: How does this area compare with my earlier images? Is biopsy needed before choosing treatment? If recurrence is confirmed, is it DCIS or invasive, and are its receptors different from before? Which operations remain possible after my previous treatment? Will the unaffected breast need different surveillance?